DVAX vs. NIO

Last updated Jun 4, 2026

DVAX (Dynavax Technologies Corporation) and NIO (NIO Inc.) are both stocks. DVAX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while NIO operates in Auto Manufacturers (Consumer Cyclical). At a 0.22 correlation, their price movements are largely independent.

Performance

DVAX vs. NIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dynavax Technologies Corporation (DVAX) and NIO Inc. (NIO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

DVAX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NIO

• 1D: -4.33%
• 1M: -5.27%
• YTD: 12.75%
• 6M: 20.04%
• 1Y: 62.89%
• 3Y*: -8.72%
• 5Y*: -32.79%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DVAX vs. NIO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
DVAX Dynavax Technologies Corporation	0.78%	20.44%	-8.66%	31.39%	-24.38%	216.18%	-22.20%	-37.49%	-23.75%
NIO NIO Inc.	12.75%	16.97%	-51.93%	-6.97%	-69.22%	-35.00%	1,112.44%	-36.89%	-3.48%

Correlation

The correlation between DVAX and NIO is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (All Time) Calculated using the full available price history since Sep 13, 2018	0.22

The correlation between DVAX and NIO shifts across timeframes, from 0.05 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap DVAX : $2.12B NIO : $14.27B
EPS DVAX : -$0.32 NIO : -$3.74
PS Ratio DVAX : 6.44 NIO : 0.14
PB Ratio DVAX : 3.96 NIO : 3.29
Total Revenue (TTM) DVAX : $330.51M NIO : $100.51B
Gross Profit (TTM) DVAX : $274.90M NIO : $15.77B
EBITDA (TTM) DVAX : -$25.65M NIO : -$7.54B

Return for Risk

DVAX vs. NIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NIO

NIO Risk / Return Rank: 67
NIO Sharpe Ratio Rank: 71
NIO Sortino Ratio Rank: 70
NIO Omega Ratio Rank: 65
NIO Calmar Ratio Rank: 67
NIO Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVAX vs. NIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dynavax Technologies Corporation (DVAX) and NIO Inc. (NIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	DVAX	NIO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.00	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.46	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.02	—

Drawdowns

Drawdown Indicators

	DVAX	NIO	Difference
Max Drawdown Largest peak-to-trough decline	—	-95.00%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-43.73%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-79.69%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-94.10%	—
Current Drawdown Current decline from peak	—	-90.85%	—
Average Drawdown Average peak-to-trough decline	—	-67.85%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	24.25%	—

Volatility

Volatility by Period

	DVAX	NIO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	18.85%	—
Volatility (6M) Calculated over the trailing 6-month period	—	41.10%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	62.97%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	71.68%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	86.72%	—

Dividends

DVAX vs. NIO - Dividend Comparison

Neither DVAX nor NIO has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

DVAX vs. NIO - Profitability Comparison

The chart below illustrates the profitability comparison between Dynavax Technologies Corporation and NIO Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DVAX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dynavax Technologies Corporation reported a gross profit of 80.47M and revenue of 94.88M. Therefore, the gross margin over that period was 84.8%.

NIO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NIO Inc. reported a gross profit of 4.86B and revenue of 25.53B. Therefore, the gross margin over that period was 19.0%.

DVAX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dynavax Technologies Corporation reported an operating income of 21.27M and revenue of 94.88M, resulting in an operating margin of 22.4%.

NIO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NIO Inc. reported an operating income of -308.81M and revenue of 25.53B, resulting in an operating margin of -1.2%.

DVAX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dynavax Technologies Corporation reported a net income of 26.93M and revenue of 94.88M, resulting in a net margin of 28.4%.

NIO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NIO Inc. reported a net income of -496.01M and revenue of 25.53B, resulting in a net margin of -1.9%.

Frequently Asked Questions

Can I hold both DVAX and NIO in my portfolio?

DVAX and NIO have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.